Advanced search×

Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision.

Jung Min Chang, Wonsik Han, Woo Kyung Moon, Nariya Cho, Dong-Young Noh, In-Ae Park, and Eun-Jung Jung

Ann Surg Oncol 18(9):2506-14 (2011) PMID 21369740

To prospectively determine the rate of malignancy after surgery in papillary lesions initially diagnosed at ultrasound (US)-guided 11-gauge vacuum-assisted breast biopsies.

DOI: 10.1245/s10434-011-1617-3
Version: za2963e q8za6 q8zbd q8zc7 q8zd0 q8zed q8zfa q8zg2

Similar articles you may find interesting…

  1. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients.
    Hei Kyung HK Choi, Nariya N Cho, ... Dong-Young DY Noh

    Eur J Radiol 81(4):737-43 (2012) PMID 21300498

    When any enhancement was present, 93% (14 of 15) sensitivity and 35% (11 of 31) specificity for the detection of residual DCIS on post-chemotherapy MRI were achieved. Although 65% (20 of 31) of lesions without residual cancer had some enhancing findings, the lesion to fibroglandular signal intensity...
  2. Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancer.
    Heidrun Gevensleben, Uwe-Jochen Göhring, ... Tobias Anzeneder

    Int J Mol Med 26(6):837-43 (2010) PMID 21042777

    I and II were classified as being low or high risk for distant metastasis using MammaPrint. Results were compared to current clinical risk classifications and adjuvant treatment management. Immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH)/chromogenic in situ hybridization (CIS...
  3. Functional magnetic resonance: biomarkers of response in breast cancer.
    Elizabeth A M EA O'Flynn and Nandita M NM DeSouza

    Breast Cancer Research (Online Edition) 13(1):204 (2011) PMID 21392409

    We describe the current state of each biomarker and explore their potential clinical uses and limitations in assessing treatment response. With the aid of selected interesting cases, biomarkers related to dynamic contrast-enhanced MRI, diffusion-weighted MRI, T2*/BOLD and MR spectroscopy are describ...